Oncogenes that promote cell-cycle progression also sensitize cells to agent
s that induce apoptosis. Sensitization is thought to be caused by the induc
tion of proapoptotic factors. Alternatively, sensitization may require the
inactivation inhibitors that ordinarily provide protection against cell dea
th. Here we show that the adenoviral oncogene EIA sensitizes cells to an an
ti-cancer drug by at least two pathways. One establishes a link between the
drug and pro-apoptotic factors, but is not sufficient for sensitization wi
thout the second pathway, which suppresses inhibitors of apoptosis.